The prevalence and risk factors of hyperuricemia in patients with Newly-diagnosed coronary artery disease from 2017 to 2021.

BACKGROUNDS: This study aimed to evaluate the prevalence and determinants of hyperuricemia in patients with newly-diagnosed coronary artery disease (CAD) after percutaneous coronary intervention. METHODS: Hyperuricemia was defined as a serum urate level of > 5.6 mg/dl. Medical records and face-to-face interviews were used to collect the demographic characteristics, medical history, lifestyle, self-management, physical examination, and laboratory examination information for each patient. Logistic regression was then used to assess the associations between hyperuricemia and several independent risk factors. RESULTS: The regression results showed that the overall prevalence of hyperuricemia was 43.2% (42.0% in men and 47.0% in women) and gender, hypertension, triglycerides, body mass index (BMI) and HbA1c were risk factors for hyperuricemia. CONCLUSIONS: Our findings suggest that the prevalence of hyperuricemia is very high in newly-diagnosed CAD patients after percutaneous coronary intervention (PCI), but the associated risk factors we identified can be ameliorated by diet and lifestyle changes.